129
Views
9
CrossRef citations to date
0
Altmetric
Review

Underrecognized comorbidities of chronic obstructive pulmonary disease

, , , &
Pages 1331-1341 | Published online: 15 Jul 2015

References

  • AgustiASobradilloPCelliBAddressing the complexity of chronic obstructive pulmonary disease: from phenotypes and biomarkers to scale-free networks, systems biology, and P4 medicineAm J Respir Crit Care Med201118391129113721169466
  • BarnesPJCelliBRSystemic manifestations and comorbidities of COPDEur Respir J20093351165118519407051
  • BorosPWLubińskiWHealth state and the quality of life in patients with chronic obstructive pulmonary disease in Poland: a study using the Euro-QoL-5D questionnairePol Arch Med Wewn20121223738122354456
  • Antonelli IncalziRFusoLDe RosaMCo-morbidity contributes to predict mortality of patients with chronic obstructive pulmonary diseaseEur Respir J19971012279428009493663
  • GlynnLGValderasJMHealyPThe prevalence of multimorbidity in primary care and its effect on health care utilization and costFam Pract201128551652321436204
  • BustacchiniSChiattiCFurneriGLattanzioFMantovaniLGThe economic burden of chronic obstructive pulmonary disease in the elderly: results from a systematic review of the literatureCurr Opin Pulm Med201117Suppl 1S35S4122209929
  • McDaidOHanlyMJRichardsonKKeeFKennyRASavvaGMThe effect of multiple chronic conditions on self-rated health, disability and quality of life among the older populations of Northern Ireland and the Republic of Ireland: a comparison of two nationally representative cross-sectional surveysBMJ Open201336e002571
  • FreiAMuggensturmPPutchaNFive comorbidities reflected the health status in patients with chronic obstructive pulmonary disease: the newly developed COMCOLD indexJ Clin Epidemiol201467890491124786594
  • Global Initiative for Chronic Obstructive Lung Disease (GOLD) [homepage on the Internet]Global strategy for the diagnosis, management, and prevention of COPDGlobal Initiative for Chronic Obstructive Lung Disease (GOLD)2015Leuven (Belgium), Marburg (Germany) Available from: http://web.archive.org/web/20150227051533/http://www.goldcopd.orgAccessed February 27, 2015
  • ItoKBarnesPJCOPD as a disease of accelerated lung agingChest2009135117318019136405
  • AmsellemVGary-BoboGMarcosETelomere dysfunction causes sustained inflammation in chronic obstructive pulmonary diseaseAm J Respir Crit Care Med2011184121358136621885626
  • ItoKColleyTMercadoNGeroprotectors as a novel therapeutic strategy for COPD, an accelerating aging diseaseInt J Chron Obstruct Pulmon Dis2012764165223055713
  • BarnesPJMechanisms of development of multimorbidity in the elderlyEur Respir J201545379080625614163
  • PapaioannouAIMaziotiAKiropoulosTSystemic and airway inflammation and the presence of emphysema in patients with COPDRespir Med2010104227528219854037
  • SalanitroAHRitchieCSHovaterMInflammatory biomarkers as predictors of hospitalization and death in community-dwelling older adultsArch Gerontol Geriatr2012543e387e39122305611
  • MoyMLTeylanMDanilackVAGagnonDRGarshickEAn index of daily step count and systemic inflammation predicts clinical outcomes in chronic obstructive pulmonary diseaseAnn Am Thorac Soc201411214915724308588
  • ManninoDMValviDMullerovaHTal-SingerRFibrinogen, COPD and mortality in a nationally representative U.S. cohortCOPD20129435936622489912
  • VanfleterenLESpruitMAGroenenMClusters of comorbidities based on validated objective measurements and systemic inflammation in patients with chronic obstructive pulmonary diseaseAm J Respir Crit Care Med2013187772873523392440
  • FuJJMcDonaldVMGibsonPGSimpsonJLSystemic inflammation in older adults with asthma-COPD overlap syndromeAllergy Asthma Immunol Res20146431632424991455
  • Garcia-AymerichJGómezFPBenetMPAC-COPD Study GroupIdentification and prospective validation of clinically relevant chronic obstructive pulmonary disease (COPD) subtypesThorax201166543043721177668
  • García-OlmosLSalvadorCHAlberquillaÁComorbidity patterns in patients with chronic diseases in general practicePLoS One201272e3214122359665
  • FokkensWJLundVJMullolJEPOS 2012: European position paper on rhinosinusitis and nasal polyps 2012. A summary for otorhinolaryngologistsRhinology201250111222469599
  • HalawiAMSmithSSChandraRKChronic rhinosinusitis: epidemiology and costAllergy Asthma Proc201334432833423883597
  • TomassenPNewsonRBHoffmansRReliability of EP3OS symptom criteria and nasal endoscopy in the assessment of chronic rhinosinusitis – a GA2 LEN studyAllergy201166455656121083566
  • HastanDFokkensWJBachertCChronic rhinosinusitis in Europe – an underestimated disease. A GA2 LEN studyAllergy20116691216122321605125
  • ChandraRKLinDTanBChronic rhinosinusitis in the setting of other chronic inflammatory diseasesAm J Otolaryngol201132538839120832903
  • LeynaertBNeukirchFDemolyPBousquetJEpidemiologic evidence for asthma and rhinitis comorbidityJ Allergy Clin Immunol20001065 SupplS201S20511080732
  • NutkuETodaMHamidQARhinitis, nasal polyposis and asthma: pathological aspectsWallaertBChanezPGodardPThe Nose and Lung Diseases. European Respiratory Monograph20016115142
  • ChenYDalesRLinMThe epidemiology of chronic rhinosinusitis in CanadiansLaryngoscope200311371199120512838019
  • RobertsNJLloyd-OwenSJRapadoFRelationship between chronic nasal and respiratory symptoms in patients with COPDRespir Med200397890991412924517
  • HurstJRWilkinsonTMDonaldsonGCWedzichaJAUpper airway symptoms and quality of life in chronic obstructive pulmonary disease (COPD)Respir Med200498876777015303642
  • HensGVanaudenaerdeBMBullensDMSinonasal pathology in nonallergic asthma and COPD: ‘united airway disease’ beyond the scope of allergyAllergy200863326126718053011
  • KelemenceAAbadogluOGumusCBerkSEpozturkKAkkurtIThe frequency of chronic rhinosinusitis/nasal polyp in COPD and its effect on the severity of COPDCOPD20118181221299473
  • NicolaMLCarvalhoHBYoshidaCTYoung “healthy” smokers have functional and inflammatory changes in the nasal and the lower airwaysChest20141455998100524307008
  • LachanasVATseaMTsiouvakaSExarchosSTSkoulakisCEBizakisJGThe effect of active cigarette smoking on Sino-Nasal Outcome Test in 127 subjects without rhinologic disease. A prospective studyClin Otolaryngol2015401565925314243
  • UhliarovaBAdamkovMSvecMCalkovskaAThe effect of smoking on CT score, bacterial colonization and distribution of inflammatory cells in the upper airways of patients with chronic rhinosinusitisInhal Toxicol201426741942524862976
  • PaceEFerraroMDi VincenzoSOxidative stress and innate immunity responses in cigarette smoke stimulated nasal epithelial cellsToxicol In Vitro201428229229924269501
  • VirginFWAzbellCSchusterDExposure to cigarette smoke condensate reduces calcium activated chloride channel transport in primary sinonasal epithelial culturesLaryngoscope201012071465146920564721
  • PiotrowskaVMPiotrowskiWJKurmanowskaZMarczakJGórskiPAntczakARhinosinusitis in COPD: symptoms, mucosal changes, nasal lavage cells and eicosanoidsInt J Chron Obstruct Pulmon Dis2010510711720631813
  • HurstJRWilkinsonTMPereraWRDonaldsonGCWedzichaJARelationships among bacteria, upper airway, lower airway, and systemic inflammation in COPDChest200512741219122615821198
  • VachierIVignolaAMChiapparaGInflammatory features of nasal mucosa in smokers with and without COPDThorax200459430330715047949
  • DaniellHWSmoker’s wrinkles. A study in the epidemiology of “crow’s feet”Ann Intern Med19717568738805134897
  • YinLMoritaATsujiTAlterations of extracellular matrix induced by tobacco smoke extractArch Dermatol Res2000292418819410836612
  • LahmannCBergemannJHarrisonGYoungARMatrix metalloproteinase-1 and skin ageing in smokersLancet2001357926093593611289356
  • KnuutinenAKokkonenNRisteliJSmoking affects collagen synthesis and extracellular matrix turnover in human skinBr J Dermatol2002146458859411966688
  • JustMRiberaMMonsóELorenzoJCFerrándizCEffect of smoking on skin elastic fibres: morphometric and immunohistochemical analysisBr J Dermatol20071561859117199572
  • OrtizAGrandoSASmoking and the skinInt J Dermatol201251325026222348557
  • BossetSBonnet-DuquennoyMBarréPPhotoageing shows histological features of chronic skin inflammation without clinical and molecular abnormalitiesBr J Dermatol2003149482683514616376
  • IddamalgodaALeQTItoKTanakaKKojimaHKidoHMast cell tryptase and photoaging: possible involvement in the degradation of extra cellular matrix and basement membrane proteinsArch Dermatol Res2008300Suppl 1S69S7617968569
  • KaukinenAFitzgibbonAOikarinenAHinkkanenLViinikanojaMHarvimaITIncreased numbers of tryptase-positive mast cells in the healthy and sun-protected skin of tobacco smokersDermatology2014229435335825376107
  • ChungJHLeeSHYounCSCutaneous photodamage in Koreans: influence of sex, sun exposure, smoking, and skin colorArch Dermatol200113781043105111493097
  • PatelBDLooWJTaskerADSmoking related COPD and facial wrinkling: is there a common susceptibility?Thorax200661756857116774949
  • MaclayJDMcAllisterDARabinovichRSystemic elastin degradation in chronic obstructive pulmonary diseaseThorax201267760661222374923
  • JustMMonsóERiberaMLorenzoJCMoreraJFerrandizCRelationships between lung function, smoking and morphology of dermal elastic fibresExp Dermatol2005141074475116176282
  • MüllerKCPaaschKFeindtBIn contrast to lung fibroblasts – no signs of senescence in skin fibroblasts of patients with emphysemaExp Gerontol200843762362818295997
  • BuckleySTEhrhardtCThe receptor for advanced glycation end products (RAGE) and the lungJ Biomed Biotechnol2010201091710820145712
  • LeeEJParkJHReceptor for advanced glycation endproducts (RAGE), its ligands, and soluble RAGE: potential biomarkers for diagnosis and therapeutic targets for human renal diseasesGenomics Inform201311422422924465234
  • MorbiniPVillaCCampoIZorzettoMInghilleriSLuisettiMThe receptor for advanced glycation end products and its ligands: a new inflammatory pathway in lung disease?Mod Pathol200619111437144516941014
  • WuLMaLNicholsonLFBlackPNAdvanced glycation end products and its receptor (RAGE) are increased in patients with COPDRespir Med2011105332933621112201
  • SmithDJYerkovichSTTowersMACarrollMLThomasRUphamJWReduced soluble receptor for advanced glycation end-products in COPDEur Respir J201137351652220595148
  • GopalPReynaertNLScheijenJLPlasma advanced glycation end-products and skin autofluorescence are increased in COPDEur Respir J201443243043823645408
  • HoonhorstSJLo Tam LoiATHartmanJEAdvanced glycation end products in the skin are enhanced in COPDMetabolism20146391149115625034386
  • PalkovitsSLastaMToldRRetinal oxygen metabolism during normoxia and hyperoxia in healthy subjectsInvest Ophthalmol Vis Sci20145584707471325015353
  • CelikCTokgözOSerifoğluLTorMAlpayAErdemZColor Doppler evaluation of the retrobulbar hemodynamic changes in chronic obstructive pulmonary disease: COPD and retrobulbar hemodynamic changesUltrason Imaging201436317718624894868
  • GonzalezAVLiGSuissaSErnstPRisk of glaucoma in elderly patients treated with inhaled corticosteroids for chronic airflow obstructionPulm Pharmacol Ther2010232657019887116
  • NesherRIsrael Glaucoma Screening GroupPrevalence of increased intraocular pressure and optic disk cupping: multicenter glaucoma screening in Israel during the 2009 and 2010 World Glaucoma WeeksIsr Med Assoc J201416848348625269338
  • HuertaCGarcía RodríguezLAMöllerCSArellanoFMThe risk of obstructive airways disease in a glaucoma populationPharmacoepidemiol Drug Saf200110215716311499855
  • SorianoJBVisickGTMuellerovaHPayvandiNHansellALPatterns of comorbidities in newly diagnosed COPD and asthma in primary careChest200512842099210716236861
  • ZlatevaGPJavittJCShahSNZhouZMurphyJGComparison of comorbid conditions between neovascular age-related macular degeneration patients and a control cohort in the medicare populationRetina20072791292129918046240
  • KleinRKnudtsonMDKleinBEPulmonary disease and age-related macular degeneration: the Beaver Dam Eye StudyArch Ophthalmol2008126684084618541850
  • SolerNGarcía-HerediaAMarsillachJParaoxonase-1 is associated with corneal endothelial cell alterations in patients with chronic obstructive pulmonary diseaseInvest Ophthalmol Vis Sci20135485852585823900603
  • DoehnerWHaeuslerKGEndresMAnkerSDMacNeeWLainscakMNeurological and endocrinological disorders: orphans in chronic obstructive pulmonary diseaseRespir Med2011105Suppl 1S12S1922015080
  • CreutzbergECCasaburiREndocrinological disturbances in chronic obstructive pulmonary diseaseEur Respir J Suppl20034676s80s14621109
  • SundarIKYaoHHuangYSerotonin and corticosterone rhythms in mice exposed to cigarette smoke and in patients with COPD: implication for COPD-associated neuropathogenesisPLoS One201492e8799924520342
  • DimopoulouIIliasIMastorakosGMantzosERoussosCKoutrasDAEffects of severity of chronic obstructive pulmonary disease on thyroid functionMetabolism200150121397140111735083
  • OkutanOKartalogluZOndeMEBozkanatEKunterEPulmonary function tests and thyroid hormone concentrations in patients with chronic obstructive pulmonary diseaseMed Princ Pract200413312612815073423
  • KaradagFOzcanHKarulABYilmazMCildagOCorrelates of non-thyroidal illness syndrome in chronic obstructive pulmonary diseaseRespir Med200710171439144617346957
  • ManciniACorboGMGaballoARelationship between plasma antioxidants and thyroid hormones in chronic obstructive pulmonary diseaseExp Clin Endocrinol Diabetes20121201062362823073919
  • BalasubramanianVNaingSHypogonadism in chronic obstructive pulmonary disease: incidence and effectsCurr Opin Pulm Med201218211211722234275
  • KarakouEGlynosCSamaraKDMsaouelPKoutsilierisMVassilakopoulosTProfile of endocrinological derangements affecting PSA values in patients with COPDIn Vivo201327564164923988900
  • CorboGMDi Marco BerardinoAManciniASerum level of testosterone, dihydrotestosterone and IGF-1 during an acute exacerbation of COPD and their relationships with inflammatory and prognostic indices: a pilot studyMinerva Med2014105428929424844347
  • LaghiFAntonescu-TurcuACollinsEHypogonadism in men with chronic obstructive pulmonary disease: prevalence and quality of lifeAm J Respir Crit Care Med2005171772873315657463
  • MousaviSAKouchariMRSamdani-FardSHGilvaeeZNArabiMRelationship between serum levels of testosterone and the severity of chronic obstructive pulmonary diseaseTanaffos2012113323525191426
  • VertkinALMorgunovLIuShakhmanaevKhAHypogonadism and chronic obstructive pulmonary diseaseUrologiia20135116118120122 Russian24437255
  • ChenYCLinYHChenSHEpidemiology of adrenal insufficiency: a nationwide study of hospitalizations in Taiwan from 1996 to 2008J Chin Med Assoc201376314014523497966
  • MartinezCHOkajimaYMurraySCOPDGene InvestigatorsImpact of self-reported gastroesophageal reflux disease in subjects from COPDGene cohortRespir Res2014156224894541
  • HardingSMGuzzoMRRichterJE24-h esophageal pH testing in asthmatics: respiratory symptom correlation with esophageal acid eventsChest1999115365465910084471
  • EmilssonOIJansonCBenediktsdóttirBJúlíussonSGíslasonTNocturnal gastroesophageal reflux, lung function and symptoms of obstructive sleep apnea: Results from an epidemiological surveyRespir Med2012106345946622197048
  • MiyazakiMNakamuraHChubachiSKeio COPD Comorbidity Research (K-CCR) GroupAnalysis of comorbid factors that increase the COPD assessment test scoresRespir Res2014151324502760
  • AjmeraMRavalADShenCSambamoorthiUExplaining the increased health care expenditures associated with gastroesophageal reflux disease among elderly Medicare beneficiaries with chronic obstructive pulmonary disease: a cost-decomposition analysisInt J Chron Obstruct Pulmon Dis2014933934824748785
  • TeradaKMuroSSatoSImpact of gastro-oesophageal reflux disease symptoms on COPD exacerbationThorax2008631195195518535116
  • BoereeMJPetersFTPostmaDSKleibeukerJHNo effects of high-dose omeprazole in patients with severe airway hyperresponsiveness and (a)symptomatic gastro-oesophageal refluxEur Respir J1998115107010749648957
  • MapelDRenal and hepatobiliary dysfunction in chronic obstructive pulmonary diseaseCurr Opin Pulm Med201420218619324370540
  • TerzanoCRomaniSPaoneGContiVOrioloFCOPD and thyroid dysfunctionsLung2014192110310924281671
  • DivoMCoteCde TorresJPBODE Collaborative GroupComorbidities and risk of mortality in patients with chronic obstructive pulmonary diseaseAm J Respir Crit Care Med2012186215516122561964
  • KimJLeeJHKimYAssociation between chronic obstructive pulmonary disease and gastroesophageal reflux disease: a national cross-sectional cohort studyBMC Pulm Med2013135123927016
  • FergusonGTCalverleyPMAndersonJAPrevalence and progression of osteoporosis in patients with COPD: results from the TOwards a Revolution in COPD Health studyChest200913661456146519581353
  • CurkendallSMDeLuiseCJonesJKCardiovascular disease in patients with chronic obstructive pulmonary disease, Saskatchewan Canada cardiovascular disease in COPD patientsAnn Epidemiol2006161637016039877
  • KellerCAShepardJWChunDSVasquezPDolanGFPulmonary hypertension in chronic obstructive pulmonary disease. Multivariate analysisChest19869021851923731890
  • FinkelsteinJChaEScharfSMChronic obstructive pulmonary disease as an independent risk factor for cardiovascular morbidityInt J Chron Obstruct Pulmon Dis2009433734919802349
  • GudmundssonGGislasonTJansonCDepression, anxiety and health status after hospitalisation for COPD: a multicentre study in the Nordic countriesRespir Med20061001879315893921
  • HananiaNAMüllerovaHLocantoreNWEvaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) study investigatorsDeterminants of depression in the ECLIPSE chronic obstructive pulmonary disease cohortAm J Respir Crit Care Med2011183560461120889909
  • MapelDWPicchiMAHurleyJSUtilization in COPD: patient characteristics and diagnostic evaluationChest20001175 Suppl 2346S53S10843975
  • KühlKSchürmannWRiefWMental disorders and quality of life in COPD patients and their spousesInt J Chron Obstruct Pulmon Dis20083472773619281087